The U.S. Food and Drug Administration (FDA) has given its green signal to Eli Lilly's angiogenesis inhibitor Cyramza (ramucirumab) to treat stomach cancer (in advanced stage) or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach. “Although the rates of stomach cancer in the United States have decreased over the past 40 years, … [Read more...]
You are here: Home / Archives for stomach cancer